Non-Small Cell Lung Cancer Market

The non-small cell lung cancer (NSCLC) market encompasses advanced treatments and diagnostics for the most common form of lung cancer. Key customers are healthcare institutions, such as hospitals and specialized oncology clinics, which procure and administer these therapies. Market growth is propelled by a rising global incidence of NSCLC, the increasing adoption of precision treatments like targeted therapies and immunotherapies, and the growing availability of companion diagnostics for personalized medicine.